Published in J Mol Cell Cardiol on August 01, 1977
Myocardial reperfusion: a double-edged sword? J Clin Invest (1985) 4.12
Tourniquets in orthopedic surgery. Indian J Orthop (2012) 2.16
State of the art in therapeutic hypothermia. Annu Rev Med (2011) 1.45
Possible pharmacological actions of magnesium in acute myocardial infarction. Br J Clin Pharmacol (1991) 1.39
Nitric oxide and cardioprotection during ischemia-reperfusion. Heart Fail Rev (2002) 1.16
Global ischaemia induces a biphasic response of the mitochondrial respiratory chain. Anoxic pre-perfusion protects against ischaemic damage. Biochem J (1992) 1.14
Alpha adrenergic-mediated accumulation of calcium in reperfused myocardium. J Clin Invest (1983) 1.09
Myocardial ischemia and reperfusion: direct evidence for free radical generation by electron spin resonance spectroscopy. Proc Natl Acad Sci U S A (1988) 1.00
Mechanisms involved in irreversible anoxic damage to the in vitro rat hippocampal slice. J Physiol (1982) 0.98
Protective effects of bradykinin on the ischaemic heart: implication of the B1 receptor. Br J Pharmacol (1993) 0.96
Effects of anoxic or oxygenated reperfusion in globally ischemic, isovolumic, perfused rat hearts. Am J Pathol (1985) 0.96
Energy dependence of contraction band formation in perfused hearts and isolated adult myocytes. Am J Pathol (1986) 0.91
The Na+/H+ exchanger: an update on structure, regulation and cardiac physiology. Biochem J (1993) 0.90
Reperfusion-induced injury: a possible role for oxidant stress and its manipulation. Cardiovasc Drugs Ther (1991) 0.90
Reperfusion injury after acute myocardial infarction. BMJ (1995) 0.89
The effect of verapamil on the calcium paradox. Am J Pathol (1980) 0.88
Transient rise in serum interleukin-8 concentration during acute myocardial infarction. Br Heart J (1993) 0.88
Calcium-related changes in the ultrastructure of mammalian myocardium. Br J Exp Pathol (1979) 0.88
The effect of dimethylsulfoxide on the calcium paradox. Am J Pathol (1981) 0.86
Inflammatory response, neutrophil activation, and free radical production after acute myocardial infarction: effect of thrombolytic treatment. Br Heart J (1990) 0.85
Role of ROS and RNS Sources in Physiological and Pathological Conditions. Oxid Med Cell Longev (2016) 0.84
Ischemia, reperfusion, and the determinants of tissue injury. Cardiovasc Drugs Ther (1990) 0.83
Catecholamine cardiomyopathy: review and analysis of pathogenetic mechanisms. Yale J Biol Med (1991) 0.82
Time-dependent changes in canine cardiac mitochondrial function and ultrastructure resulting from coronary occlusion and reperfusion. Basic Res Cardiol (1981) 0.81
A direct protective effect of sulphinpyrazone on ischaemic and reperfused rat hearts. Br J Pharmacol (1984) 0.80
A possible mechanism of glycolytic impairment after adenosine triphosphate deplection in the perfused rat heart. J Physiol (1980) 0.79
The cardioprotective effect of gamma-glutamylcysteine ethyl ester during coronary reperfusion in canine hearts. Br J Pharmacol (1991) 0.77
Beneficial effect of amosulalol and phentolamine on post-hypoxic recovery of contractile force and energy metabolism in rabbit hearts. Br J Pharmacol (1989) 0.77
The occurrence of oxidative stress during reperfusion in experimental animals and men. Cardiovasc Drugs Ther (1991) 0.77
Protective effects of calcium antagonists against ischaemia and reperfusion damage. Drugs (1991) 0.77
Nitric oxide and cardiovascular protection. Heart Fail Rev (2003) 0.77
Use of hypothermia in the intensive care unit. World J Crit Care Med (2012) 0.77
Depletion of membrane phospholipid and mitochondrial dysfunction associated with coronary reperfusion. Basic Res Cardiol (1985) 0.77
Calcium gain during postischemic reperfusion. The effect of 2,4-dinitrophenol. Am J Pathol (1988) 0.76
The role of post-ischaemic reperfusion in the development of microvascular incompetence and ultrastructural damage in the myocardium. Basic Res Cardiol (1992) 0.76
The antiarrhythmic efficacy of intravenous anipamil against occlusion and reperfusion arrhythmias. Br J Pharmacol (1989) 0.75
Effects of dantrolene on arrhythmogenicity in isolated regional ischemia-reperfusion rabbit hearts with or without pacing-induced heart failure. Biomed Res Int (2015) 0.75
Role of cardiac renin angiotensin system in ischemia reperfusion injury and preconditioning of heart. Indian Heart J (2016) 0.75
Effects of chloroquine and Nifedipine on the phospholipid content and enzyme activity in the subcellular fraction of ischemic rat liver. Basic Res Cardiol (1982) 0.75
Avoidance of reperfusion injury after cardioplegia. Thorax (1982) 0.75
Beneficial actions of acidotic initial reperfusate in stunned myocardium of rat hearts. Basic Res Cardiol (1992) 0.75
Response of cyt a,a3 in the situ canine heart to transient ischemic episodes. Basic Res Cardiol (1981) 0.75
Effects of brief ischemia and reperfusion on the myocardium and the role of nitric oxide. Heart Fail Rev (2003) 0.75
Reversible and irreversible damage in reoxygenated 'ischemic' ventricular myocytes in culture. Mol Cell Biochem (1997) 0.75
The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia infarction, and reperfusion. Cardiovasc Res (1988) 3.98
Myocardial ischaemia: can we agree on a definition for the 21st century? Cardiovasc Res (1994) 2.16
Reperfusion-induced arrhythmias: mechanisms and prevention. J Mol Cell Cardiol (1984) 2.00
The oxygen paradox and the calcium paradox: two facets of the same problem? J Mol Cell Cardiol (1978) 1.95
Species variation in the coronary collateral circulation during regional myocardial ischaemia: a critical determinant of the rate of evolution and extent of myocardial infarction. Cardiovasc Res (1987) 1.83
Abrupt reoxygenation of the anoxic potassium-arrested perfused rat heart: a study of myocardial enzyme release. J Mol Cell Cardiol (1973) 1.77
Direct detection of free radicals in the reperfused rat heart using electron spin resonance spectroscopy. Circ Res (1987) 1.74
Formation of 4-hydroxy-2-nonenal-modified proteins in ischemic rat heart. Am J Physiol (1999) 1.61
Ischemic contracture of the myocardium: mechanisms and prevention. Am J Cardiol (1977) 1.61
Reperfusion-induced arrhythmias and oxygen-derived free radicals. Studies with "anti-free radical" interventions and a free radical-generating system in the isolated perfused rat heart. Circ Res (1986) 1.52
The influence of some physico-chemical factors on the biliary excretion of a series of structurally related aryl sulphate esters. Biochem Pharmacol (1969) 1.51
Oxygen deprivation and early myocardial contractile failure: a reassessment of the possible role of adenosine triphosphate. Am J Cardiol (1979) 1.48
The antiarrhythmic action of ischaemic preconditioning in rat hearts does not involve functional Gi proteins. Cardiovasc Res (1993) 1.46
Protection of the immature myocardium during global ischemia. A comparison of four clinical cardioplegic solutions in the rabbit heart. J Thorac Cardiovasc Surg (1989) 1.43
Optimal myocardial protection during crystalloid cardioplegia. Interrelationship between volume and duration of infusion. J Thorac Cardiovasc Surg (1988) 1.43
Ischemia and reperfusion-induced arrhythmias in the rat. Effects of xanthine oxidase inhibition with allopurinol. Circ Res (1984) 1.39
Harvesting hearts for long-term preservation. Detrimental effects of initial hypothermic infusion of cardioplegic solutions. J Thorac Cardiovasc Surg (1990) 1.38
Preconditioning of ischemic myocardium: reperfusion-induced arrhythmias. Am J Physiol (1987) 1.35
The isolated blood and perfusion fluid perfused heart. Pharmacol Res (2000) 1.34
Xanthine oxidase: a critical mediator of myocardial injury during ischemia and reperfusion? Acta Physiol Scand Suppl (1986) 1.26
Hypothermic arrest and potassium arrest: metabolic and myocardial protection during elective cardiac arrest. Circ Res (1975) 1.25
Ischaemia-induced and reperfusion-induced arrhythmias differ in their sensitivity to potassium: implications for mechanisms of initiation and maintenance of ventricular fibrillation. J Mol Cell Cardiol (1989) 1.23
The role of glucose in the survival and 'recovery' of the anoxic isolated perfused rat heart. Biochem J (1972) 1.20
The "border zone" in evolving myocardial infarction: controversy or confusion? Am J Cardiol (1981) 1.14
Coronary vascular responsiveness to 5-hydroxytryptamine before and after infusion of hyperkalemic crystalloid cardioplegic solution in the rat heart. Possible evidence of endothelial damage. J Thorac Cardiovasc Surg (1989) 1.13
Creatine kinase isoenzymes: their separation and quantitation. Cardiovasc Res (1977) 1.12
Multiple N-acetyltransferases and drug metabolism. Tissue distribution, characterization and significance of mammalian N-acetyltransferase. Biochem J (1973) 1.12
Myocardial protection during ischemic cardiac arrest. A possible hazard with calcium-free cardioplegic infusates. J Thorac Cardiovasc Surg (1977) 1.09
Free radicals and reperfusion-induced arrhythmias: protection by spin trap agent PBN in the rat heart. Circ Res (1987) 1.08
Improved functional recovery by ischaemic preconditioning is not mediated by adenosine in the globally ischaemic isolated rat heart. Cardiovasc Res (1993) 1.08
Regulation of sarcolemmal Na(+)/H(+) exchanger activity by angiotensin II in adult rat ventricular myocytes: opposing actions via AT(1) versus AT(2) receptors. Circ Res (1999) 1.07
Ultrastructural damage associated with reoxygenation of the anoxic myocardium. J Mol Cell Cardiol (1975) 1.06
Reperfusion-induced arrhythmias are critically dependent upon occluded zone size: relevance to the mechanism of arrhythmogenesis. J Mol Cell Cardiol (1989) 1.04
Cellular protection during myocardial ischemia: the development and characterization of a procedure for the induction of reversible ischemic arrest. Circulation (1976) 1.03
Enzyme release during myocardial anoxia: a study of metabolic protection. J Mol Cell Cardiol (1975) 1.01
Ischemia-induced and reperfusion-induced arrhythmias: importance of heart rate. Am J Physiol (1989) 1.00
Recovery from cardiac bypass and elective cardiac arrest. The metabolic consequences of various cardioplegic procedures in the isolated rat heart. Circ Res (1974) 0.99
The calcium paradox: metabolic, electrophysiological, contractile and ultrastructural characteristics in four species. Eur J Cardiol (1978) 0.99
Cold cardioplegia or continuous coronary perfusion? Report on preliminary clinical experience as assessed cytochemically. J Thorac Cardiovasc Surg (1977) 0.98
Myocardial protection during ischemic cardiac arrest. The importance of magnesium in cardioplegic infusates. J Thorac Cardiovasc Surg (1978) 0.97
Temporal and spatial characteristics of evolving cell injury during regional myocardial ischemia in the dog: the "border zone" controversy. J Am Coll Cardiol (1983) 0.96
Brain death-induced impairment of cardiac contractile performance can be reversed by explantation and may not preclude the use of hearts for transplantation. Circ Res (1992) 0.96
Sustained limitation of myocardial necrosis 24 hours after coronary artery occlusion: verapamil infusion in dogs with small myocardial infarcts. Am J Cardiol (1983) 0.94
Xanthine oxidase is not a source of free radicals in the ischemic rabbit heart. J Mol Cell Cardiol (1987) 0.94
Diabetes and the survival and recovery of the anoxic myocardium. J Mol Cell Cardiol (1975) 0.94
Developments in cardioprotection: "polarized" arrest as an alternative to "depolarized" arrest. Ann Thorac Surg (1999) 0.94
The metabolic fate and elimination of streptozotocin. Biochem Soc Trans (1975) 0.94
Verapamil and the calcium paradox. J Mol Cell Cardiol (1980) 0.93
"Dose"-dependency and temporal characteristics of protection by ischaemic preconditioning against ischaemia-induced arrhythmias in rat hearts. J Mol Cell Cardiol (1993) 0.93
The temperature dependence of the calcium paradox: enzymatic, functional and morphological correlates of cellular injury. J Mol Cell Cardiol (1983) 0.92
Reperfusion-induced arrhythmias and free radicals: studies in the rat heart with DMPO. J Cardiovasc Pharmacol (1987) 0.91
Preconditioning and reperfusion arrhythmias in the isolated rat heart: true protection or temporal shift in vulnerability? Cardiovasc Res (1993) 0.91
Role of protein kinase C in ischemic preconditioning: player or spectator? Circ Res (1996) 0.90
Reperfusion-induced arrhythmias: mechanisms of protection by glucose and mannitol. Am J Physiol (1988) 0.90
Particle-induced coronary vasoconstriction during cardioplegic infusion. Characterization and possible mechanisms. J Thorac Cardiovasc Surg (1985) 0.90
Reperfusion arrhythmias: dose-related protection by anti-free radical interventions. Am J Physiol (1989) 0.90
Effects of potassium channel modulation during global ischaemia in isolated rat heart with and without cardioplegia. Cardiovasc Res (1992) 0.89
The synthesis of [14C] streptozotocin and its distribution and excretion in the rat. Biochem J (1974) 0.89
Characterization of the lateral interface between normal and ischemic tissue in the canine heart during evolving myocardial infarction. Am J Cardiol (1981) 0.89
Cardioplegia and slow calcium-channel blockers. Studies with verapamil. J Thorac Cardiovasc Surg (1983) 0.88
Calcium antagonists and hypothermia: the temperature dependency of the negative inotropic and anti-ischemic properties of verapamil in the isolated rat heart. Circulation (1984) 0.88
Slow calcium channel blockers and the calcium paradox: comparative studies in the rat with seven drugs. J Mol Cell Cardiol (1983) 0.87
Reactive oxygen species modify the structure and function of the cardiac sarcoplasmic reticulum calcium-release channel. Cardioscience (1991) 0.87
Species variation in myocardial anoxic enzyme release, glucose protection and reoxygenation damage. J Mol Cell Cardiol (1976) 0.87
Na+/H+ exchanger activity does not contribute to protection by ischemic preconditioning in the isolated rat heart. Circulation (1997) 0.86
Free radicals and cardioplegia: allopurinol and oxypurinol reduce myocardial injury following ischemic arrest. Ann Thorac Surg (1987) 0.86
Protection of the pediatric myocardium. Differential susceptibility to ischemic injury of the neonatal rat heart. J Thorac Cardiovasc Surg (1987) 0.86
Combined administration of an IK(ATP) activator and Ito blocker increases coronary flow independently of effects on heart rate, QT interval, and ischaemia-induced ventricular fibrillation in rats. J Cardiovasc Pharmacol (1993) 0.86
Regional myocardial ischemia: characterization of temporal, transmural and lateral flow interfaces in the porcine heart. Can J Cardiol (1986) 0.86
Effects of R-56865 on transient inward current, Na(+)-Ca2+ exchange, and Ca2+ release from SR in cardiac myocytes. Am J Physiol (1994) 0.85
The preparation and characterization of a series of 35S-labelled aryl sulphate esters for metabolic studies. Biochem Pharmacol (1969) 0.85
Ischemia- and reperfusion-induced arrhythmias: beneficial actions of nifedipine. J Cardiovasc Pharmacol (1987) 0.85
Acadesine and myocardial protection. Studies of time of administration and dose-response relations in the rat. Circulation (1992) 0.85
Protection of the myocardium during ischemic arrest: possible toxicity of carnitine in cardioplegic solutions. Thorac Cardiovasc Surg (1980) 0.85
Myocardial protection during ischemic cardiac arrest. Possible deleterious effects of glucose and mannitol in coronary infusates. J Thorac Cardiovasc Surg (1978) 0.85
Microbiopsy metabolite and paired flow analysis: a new rapid procedure for homogenisation, extraction and analysis of high energy phosphates and other intermediates without any errors from tissue loss. Cardiovasc Res (1984) 0.84
N-acetylation of drugs. Pharmacogenetic studies in rabbits selected for their acetylator characteristics. Drug Metab Dispos (1976) 0.84
Sustained protection by acadesine against ischemia- and reperfusion-induced injury. Studies in the transplanted rat heart. Circulation (1992) 0.84
The St. Thomas' hospital cardioplegic solution: a characterization in two species. Scand J Thorac Cardiovasc Surg Suppl (1981) 0.84
Na+/H+ exchanger inhibitor HOE-642 improves cardioplegic myocardial preservation under both normothermic and hypothermic conditions. Circulation (1997) 0.84
Protection of the ischemic myocardium. Ultrastructural, enzymatic, and functional assessment of the efficacy of various cardioplegic infusates. J Thorac Cardiovasc Surg (1978) 0.84
Ischaemic preconditioning and contractile function: studies with normothermic and hypothermic global ischaemia. J Mol Cell Cardiol (1992) 0.84
Effects of flurbiprofen in altering the size of myocardial infarcts in dogs: reduction or delay? Am J Cardiol (1983) 0.84
Singlet oxygen and myocardial injury: ultrastructural, cytochemical and electrocardiographic consequences of photoactivation of rose bengal. J Mol Cell Cardiol (1990) 0.83
Na+/H+ exchange and reperfusion arrhythmias: protection by intracoronary infusion of a novel inhibitor. Am J Physiol (1994) 0.83
Inotropic agents and functional recovery from ischemic cardiac arrest. Thorac Cardiovasc Surg (1979) 0.83
Effect of glucose on enzyme release from, and recovery of, the anoxic myocardium. Recent Adv Stud Cardiac Struct Metab (1973) 0.83
Oxygen supply and oxygen demand in the isolated working rabbit heart perfused with asanguineous crystalloid solution. Cardiovasc Res (1991) 0.83
Oxidant stress inhibits Na-Ca-exchange current in cardiac myocytes: mediation by sulfhydryl groups? Am J Physiol (1994) 0.83
R56865, a potent new antiarrhythmic agent, effective during ischemia and reperfusion in the rat heart. J Cardiovasc Pharmacol (1990) 0.83
Thromboxane A2 mediates pulmonary hypertension after cardiopulmonary bypass in the rabbit. J Thorac Cardiovasc Surg (1993) 0.82
Autoradiographic study of the distribution and cellular uptake of (14C) - streptozotocin in the rat. Diabetologia (1976) 0.82
Singlet oxygen-induced arrhythmias. Dose- and light-response studies for photoactivation of rose bengal in the rat heart. Circulation (1989) 0.82
Metoprolol reduces reperfusion-induced fibrillation in the isolated rat heart: protection is secondary to bradycardia. J Cardiovasc Pharmacol (1987) 0.82
Streptozotocin: its excretion and metabolism in the rat. Diabetologia (1976) 0.82
Species differences in susceptibility to ischemic injury and responsiveness to myocardial protection. Cardioscience (1990) 0.82
The genesis of arrhythmias during myocardial ischemia. Dissociation between changes in cyclic adenosine monophosphate and electrical instability in the rat. Circ Res (1985) 0.82
The application of whole-body autoradiography to a study of the distribution, metabolism and mode of excretion of 35S-labelled aryl sulphate esters. Biochem Pharmacol (1969) 0.82
Ischemic preconditioning: a potential role for constitutive low molecular weight stress protein translocation and phosphorylation? J Mol Cell Cardiol (2000) 0.82
Paradoxical effect of ischemic preconditioning on ischemic contracture? NMR studies of energy metabolism and intracellular pH in the rat heart. J Mol Cell Cardiol (1996) 0.82